Institutional Intelligence 
Market Intelligence
Regulatory milestones, strategic partnerships, clinical developments, and NDP 2030 alignment updates. Structured for board-level review and institutional analysis.
Featured Briefing 2025-09-12
IFC Announces $7M Investment to Support Biovac's Vaccine Manufacturing Expansion
The International Finance Corporation commits to Biovac's capacity expansion programme, supporting the transition from fill-and-finish to end-to-end drug substance manufacturing. This investment anchors the 9-DFI consortium backing Biovac's continental vaccine mandate.